Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment?

Psychoneuroendocrinology

Volumn 21, Issue 4, 1996, Pages 411-419

  Thibaut, Florence ^a,c   Cordier, Bernard ^b   Kuhn, Jean Marc ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b FOCH HOSPITAL   (France)

^c CHS du Rouvray   (France)

Author keywords

GnRH a; Paraphilia; Sex offenders; Testosterone

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; GONADORELIN AGONIST; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIPTORELIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PEDOPHILIA; PRIORITY JOURNAL;

EID: 0030152099     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4530(96)00004-2     Document Type: Article

References (18)

1. Awoniyi CA, Reece MS, Hurst BS, Faber KA, Chandrashekar V, Schlaff WD (1993) Maintenance of sexual function with testosterone in the gonadotrophin-releasing-hormone immunized hypogonadotropic infertile male rat. Biol Reprod 49:1170-1176.
2. Bradford JM (1983) Research on sex offenders. Psychiatr Clin North Am 6:715-731.
3. Bradford JM (1988) Organic treatment for the male sexual offender. Ann NY Acad Sci 528:193-202.
4. Bradford JM, Pawlak MA (1987) Sadistic homosexual pedophilia: treatment with cyproterone acetate: a single case study. Can J Psychiatry 32:22-30.
5. Cooper AJ (1986) Progestogens in the treatment of male sex offenders: a review. Can J Psychiatry 31:73-79.
6. Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z (1992) A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry 37:687-693.
7. Davies TS (1974) Cyproterone acetate for male hypersexuality. J Int Med Res 2:159-163.
8. Dickey R (1992) The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 37:567-569.
9. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD (1990) Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 70:1330-1333.
10. Gooren LJ (1987) Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav 16:463-473.
11. Kendrick KM, Dixson AF (1985) Luteinizing hormone releasing hormone enhances proceptivity in a primate. Neuroendocrinology 41:449-453.
12. Mahoudeau JA, Walcke JC, Bricaire H (1975) Dissociated responses of plasma testosterone and estradiol to human chorionic gonadotrophin in adult men. J Clin Endocrinol Metab 41:13-20.
13. Moss RL, Dudley CA (1989) Luteinizing hormone-releasing-hormone (LHRH): peptidergic signals in the neural integration of female reproductive behavior. In: Lakoski JM, Perez-Polo JR, Rassin DK (Eds) Neural Control of Reproductive Function. Liss, New York, pp 485-499.
14. Odell WD, Ross GT, Rayfold PL (1967) Radioimmunoassay of luteinizing hormone in plasma or serum. J Clin Invest 46:248-255.
15. Rousseau L, Couture M, Dupont A, Labrie F, Couture N (1990) Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry 35:338-341.
16. Thibaut F, Cordier B, Kuhn JM (1993) Effect of a long-lasting gonadrotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 87:445-450.
17. Thibaut F, Kuhn JM, Colonna L (1991) A possible antiaggressive effect of cyproterone acetate. Br J Psychiatry 159:298-299.
18. Warriar N, Page N, Koutsilieris M, Govindan MV (1994) Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Prostate 24:176-186.